Видео ютуба по тегу Il-5 Inhibitor

MoA Review: Anti-IL-5 Therapy
MoA Review: Anti-IL-5 Therapy
IL-5–Inhibiting Agents Mepolizumab, Benralizumab, and Reslizumab
IL-5–Inhibiting Agents Mepolizumab, Benralizumab, and Reslizumab
Anti IL5 and Indicators for Use
Anti IL5 and Indicators for Use
Dr Anne Reihman: AntiIL-5 Therapies Can Be Life-Changing for Patients With Eosinophilic Asthma
Dr Anne Reihman: AntiIL-5 Therapies Can Be Life-Changing for Patients With Eosinophilic Asthma
Anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for both
Anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for both
Breathe Easier: Eosinophilic Severe Asthma Treatment
Breathe Easier: Eosinophilic Severe Asthma Treatment
AAAAI: Mepolizumab Can Replace Steroids in Hypereosinophilic
AAAAI: Mepolizumab Can Replace Steroids in Hypereosinophilic
in 5 min: IL4 IL5 IL13 and JAK1 in allergic and atopic responses
in 5 min: IL4 IL5 IL13 and JAK1 in allergic and atopic responses
Cytokines
Cytokines
Interleukins and its role in immune system | Interleukin function
Interleukins and its role in immune system | Interleukin function
Cytokines of Adaptive Immunity | IL-2 | IL-4 | IL-5 | TGF-β | INF- γ | Basic Science Series
Cytokines of Adaptive Immunity | IL-2 | IL-4 | IL-5 | TGF-β | INF- γ | Basic Science Series
Drugs for Asthma Treatment
Drugs for Asthma Treatment
Webinar: Biologic Therapy for Patients with Severe Asthma
Webinar: Biologic Therapy for Patients with Severe Asthma
Overview of EGPA 2024
Overview of EGPA 2024
Механизм действия ингибиторов JAK
Механизм действия ингибиторов JAK
Advances in the Management of Allergic and Inflammatory Diseases
Advances in the Management of Allergic and Inflammatory Diseases
Allergies, Atopies, Cells, Cytokines and JAK signaling.
Allergies, Atopies, Cells, Cytokines and JAK signaling.
Risankizumab vs. Ustekinumab for Psoriasis
Risankizumab vs. Ustekinumab for Psoriasis
Targeting TSLP in Severe Asthma - Video abstract [ID 275039]
Targeting TSLP in Severe Asthma - Video abstract [ID 275039]
IL-13 Inhibitors for the Treatment of Moderate-to-Severe Atopic Dermatitis | Peter Lio, MD
IL-13 Inhibitors for the Treatment of Moderate-to-Severe Atopic Dermatitis | Peter Lio, MD